Texas 2013 83rd Regular

Texas Senate Bill SB190 Senate Committee Report / Fiscal Note

Filed 02/01/2025

Download
.pdf .doc .html
                    LEGISLATIVE BUDGET BOARD    Austin, Texas      FISCAL NOTE, 83RD LEGISLATIVE REGULAR SESSION            February 20, 2013      TO: Honorable Jane Nelson, Chair, Senate Committee on Health & Human Services      FROM: Ursula Parks, Director, Legislative Budget Board     IN RE:SB190 by Huffman (Relating to the prescription and pharmaceutical substitution of biological products.), Committee Report 1st House, Substituted    No significant fiscal implication to the State is anticipated.  The bill would amend the Occupations Code relating to prescription and substitution requirements for biological products. Based on information provided by the Board of Pharmacy, it is assumed that the provisions of the bill could be implemented by utilizing existing agency resources. Local Government Impact No fiscal implication to units of local government is anticipated.    Source Agencies:515 Board of Pharmacy   LBB Staff:  UP, CL, MW, ED    

LEGISLATIVE BUDGET BOARD
Austin, Texas
FISCAL NOTE, 83RD LEGISLATIVE REGULAR SESSION
February 20, 2013





  TO: Honorable Jane Nelson, Chair, Senate Committee on Health & Human Services      FROM: Ursula Parks, Director, Legislative Budget Board     IN RE:SB190 by Huffman (Relating to the prescription and pharmaceutical substitution of biological products.), Committee Report 1st House, Substituted  

TO: Honorable Jane Nelson, Chair, Senate Committee on Health & Human Services
FROM: Ursula Parks, Director, Legislative Budget Board
IN RE: SB190 by Huffman (Relating to the prescription and pharmaceutical substitution of biological products.), Committee Report 1st House, Substituted

 Honorable Jane Nelson, Chair, Senate Committee on Health & Human Services 

 Honorable Jane Nelson, Chair, Senate Committee on Health & Human Services 

 Ursula Parks, Director, Legislative Budget Board

 Ursula Parks, Director, Legislative Budget Board

SB190 by Huffman (Relating to the prescription and pharmaceutical substitution of biological products.), Committee Report 1st House, Substituted

SB190 by Huffman (Relating to the prescription and pharmaceutical substitution of biological products.), Committee Report 1st House, Substituted



No significant fiscal implication to the State is anticipated.

No significant fiscal implication to the State is anticipated.



The bill would amend the Occupations Code relating to prescription and substitution requirements for biological products. Based on information provided by the Board of Pharmacy, it is assumed that the provisions of the bill could be implemented by utilizing existing agency resources.

Local Government Impact

No fiscal implication to units of local government is anticipated.

Source Agencies: 515 Board of Pharmacy

515 Board of Pharmacy

LBB Staff: UP, CL, MW, ED

 UP, CL, MW, ED